Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. J. Bond ClementCFO | -3,19k | 62,50k | Sale to Issuer | 19,61 | 57,33k | -5,27% |
| 2026-05-18 | Mr. J. Bond ClementCFO | -12,55k | 252,08k | Vendita | 20,08 | 57,33k | -17,96% |
| 2026-05-15 | Dr. Ryan Gillis EzellCEO & Director | -4,78k | 93,74k | Sale to Issuer | 19,61 | 147,17k | -3,15% |
| 2026-03-13 | ProFrac Holding Corp.Società | 6,00M | 600,00 | Derivative Exercise and Retained Stock | 0,00 | 21,06M | 39,84% |
| 2026-02-24 | Mr. J. Bond ClementCFO | -6,30k | 100,91k | Sale to Issuer | 16,02 | 81,48k | -7,18% |
| 2026-02-24 | Dr. Ryan Gillis EzellCEO & Director | -12,13k | 194,26k | Sale to Issuer | 16,02 | 139,35k | -8,01% |
| 2025-12-19 | Mr. J. Bond ClementCFO | -3,25k | 52,88k | Sale to Issuer | 16,26 | 72,63k | -4,29% |
| 2025-12-05 | Dr. Ryan Gillis EzellCEO & Director | -1,83k | 30,02k | Sale to Issuer | 16,38 | 121,22k | -1,49% |
| 2025-12-05 | Mr. J. Bond ClementCFO | -1,33k | 21,83k | Sale to Issuer | 16,38 | 75,88k | -1,73% |
| 2025-11-13 | Mr. Harsha V. AgadiNon-Executive Chairman | -66,96k | 984,65k | Vendita | 14,71 | 222,68k | -23,12% |
| 2025-10-30 | Ms. Amy E. BlakewayInsider | 3,64k | 0,00 | Derivative Exercise and Retained Stock | - | 12,95k | 39,08% |
| 2025-10-30 | Ms. Amy E. BlakewayInsider | -2,36k | 44,27k | Derivative Exercise and Sale | 18,75 | 12,95k | - |
| 2025-10-30 | Ms. Amy E. BlakewayInsider | -1,57k | 29,51k | Sale to Issuer | 18,75 | 12,95k | -10,84% |
| 2025-10-30 | Mr. J. Bond ClementCFO | 9,10k | 0,00 | Derivative Exercise and Retained Stock | - | 73,83k | 14,05% |
| 2025-10-30 | Mr. J. Bond ClementCFO | -5,90k | 110,68k | Derivative Exercise and Sale | 18,75 | 73,83k | - |
| 2025-10-30 | Mr. J. Bond ClementCFO | -3,94k | 73,78k | Sale to Issuer | 18,75 | 73,83k | -5,06% |
| 2025-10-30 | Dr. Ryan Gillis EzellCEO & Director | 18,20k | 0,00 | Derivative Exercise and Retained Stock | - | 118,39k | 18,16% |
| 2025-10-30 | Dr. Ryan Gillis EzellCEO & Director | -11,81k | 221,34k | Derivative Exercise and Sale | 18,75 | 118,39k | - |
| 2025-10-30 | Dr. Ryan Gillis EzellCEO & Director | -7,87k | 147,56k | Sale to Issuer | 18,75 | 118,39k | -6,23% |
| 2025-08-14 | Dr. Ryan Gillis EzellCEO & Director | -87,19k | 652,66k | Derivative Exercise and Sale | 3,28 - 12,26 | 87,54k | - |
| 2025-08-14 | Dr. Ryan Gillis EzellCEO & Director | -7,50k | 0,00 | Other Disposition | - | 87,54k | -7,89% |
| 2025-08-13 | Mr. J. Bond ClementCFO | -45,73k | 432,62k | Derivative Exercise and Sale | 3,28 - 12,74 | 58,66k | - |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
